The data were released during the 2024 San Antonio Breast Cancer Symposium. ... Fierce Biotech · Fierce Healthcare · Fierce Pharma. Our Events. Life ...
News
- SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer
- Lilly's imlunestrant takes aim at oral SERD market | Pharmaceutical | The Pharmaletter
A clinical-stage biotechnology company focused on delivering innovative immunology therapeutics.
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer Symposium (SABCS). The poster is now ...
- TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ...
... San Antonio, TX.1 A copy of the poster is available here ... Psyence Biomedical executes binding agreements with Optimi Health.
- ALX Oncology Sets Key Data Review: Evorpacept Breast Cancer Trial Results From SABCS 2024
... San Antonio Breast Cancer Symposium (SABCS). The event will feature Dr. Alberto J. Montero, Clinical Director of Breast Cancer Medical Oncology at ...